INVESTOR PRESENTATION - OSTEOPORE LIMITED
OSTEOPORE LIMITED
Health Care
Osteopore specialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. Osteopore's products are manufactured in-house using 3D printing technology that is precise and allows for customisation of shape and geometry. The unique 3D printed biomimetic micro architecture of the 3D scaffolding which is contained within the Osteopore products provides for infiltration of cells and blood vessels, both of which play key roles in wound healing and tissue repair. Osteopore products are made of a US FDA approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possesses mechanical strength similar to trabecular bone.
Read moreMarket Cap
38.13m
Price at Close
$0.615
4w avg. Volume
187.27k
4w avg. Turnover
$123.94k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| -6.25% | 31 Jul 2020 |
| -6.25% | 31 Jul 2020 |
| -3.88% | 22 Jul 2020 |
| -21.56% | 02 Jul 2020 |
| -21.56% | 02 Jul 2020 |
| +63.75% | 01 Jul 2020 |
| -4.44% | 23 Jun 2020 |
| -8.99% | 11 Jun 2020 |
| -8.99% | 11 Jun 2020 |
| -5.94% | 05 Jun 2020 |
Market Data
Current Price
$0.615
52WK HIGH
$1.49
52WK LOW
$0.275
1YR RETURN
-15.17%
1YR RETURN VS. SECTOR
-47.77%
90 DAY RETURN
+24.24%
ASX RANK
1,106
/2,032
SECTOR RANK
5
/8
SHARES OUTSTANDING
62.00m
OSTEOPORE LIMITED
Health Care
Osteopore specialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. Osteopore's products are manufactured in-house using 3D printing technology that is precise and allows for customisation of shape and geometry. The unique 3D printed biomimetic micro architecture of the 3D scaffolding which is contained within the Osteopore products provides for infiltration of cells and blood vessels, both of which play key roles in wound healing and tissue repair. Osteopore products are made of a US FDA approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possesses mechanical strength similar to trabecular bone.
Read moreMarket Cap
38.13m
Price at Close
$0.615
4w avg. Volume
187.27k
4w avg. Turnover
$123.94k
ASX:OSX is not raising right now
Want to invest?
Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Contact Us
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia
(03) 9028 2888
deals@freshequities.com
Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.